LODH IMMUNOLOGY FUND
The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank. Approximately 20% of the assets of the fund are invested in privately held biotech companies.
LODH IMMUNOLOGY FUND
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2009-05-12 | NovImmune | LODH Immunology Fund investment in Venture Round - NovImmune | 54.8 M USD |
| 2006-06-01 | NovImmune | LODH Immunology Fund investment in Series B - NovImmune | 46 M USD |
| 2002-05-14 | ESBATech | LODH Immunology Fund investment in Series A - ESBATech | 14.5 M CHF |
| 2001-09-27 | 7TM Pharma | LODH Immunology Fund investment in Series A - 7TM Pharma | 15 M USD |
| 2000-06-13 | Genmab | LODH Immunology Fund investment in Venture Round - Genmab | 40.5 M USD |
| 2000-05-01 | NovImmune | LODH Immunology Fund investment in Series A - NovImmune | 14 M USD |